Clinical features of women’s depending of paroxetine (paxil) and their treatment
نویسندگان
چکیده
Objective: The aim of this work was study of clinical features of women’s depending of Paxil. Materials and methods: A structured clinical interview, according to the checklist of diagnostic criteria of ICD-10 (Psychoactive Substance Use Syndromes Module). Ten women patients depending of paxil were studied. Results: It was found that the main clinical features depending on Paxil in women are: the prevalence of the clinical picture of mental disorders such as psychosis (atypical form of delirium) and non-psychotic, excessive agitation, suicidal attempts, prone to aggressive actions to themselves or others, autonomic, somatic, and neurological and other disorders. Conclusion: Our data suggest that treatment depending of paxil must be direction to psychopathological sings, which appeared clinical picture of the illness. Correspondence to: Nadir A. Aliyev, Department of Psychiatry and Addiction Institute of Postgraduate Medical named A. Aliyev of Azerbaijan Republic of the Ministry of the Health, Baku City, U. Chagibekov Street, 46/50, F. 1. Baku P.O. AZ0010, Azerbaijan Republic, Tel: +86 25 663 7551; E-mail: [email protected]
منابع مشابه
Clinical Research Brief: Increased risk of breast cancer recurrence in women initiating tamoxifen with CYP2D6 inhibitors. Available at www.medcoresearch.com. Drug Trade Names: citalopram—Celexa; escitalopram—Lexapro; fluoxetine—Prozac; fluvoxamine—Luvox; paroxetine—Paxil; sertraline—Zoloft; tamoxifen—Nolvadex Add-On Aripiprazole Reduced Weight
Results: Overall, women who took tamoxifen plus a CYP2D6 inhibitor (mean duration of concurrent treatment, 340 days) had a nearly 2-fold increase in breast cancer recurrence, compared with those who took tamoxifen alone (14% vs 7.5%; p<0.001). Concurrent users of one of the moderate/potent CYP2D6 inhibiting SSRIs (i.e., fluoxetine, paroxetine, sertraline) had the highest recurrence rate (16%). ...
متن کاملMechanism of Paroxetine (Paxil) Inhibition of the Serotonin Transporter
The serotonin transporter (SERT) is an integral membrane protein that exploits preexisting sodium-, chloride-, and potassium ion gradients to catalyze the thermodynamically unfavorable movement of synaptic serotonin into the presynaptic neuron. SERT has garnered significant clinical attention partly because it is the target of multiple psychoactive agents, including the antidepressant paroxetin...
متن کاملA Comparative Study of Anxiety Disorders Treatment with Paroxetine Associated with Cranial Electrotherapy Stimulation Therapy
Objective: To explore the add-on effect of cranial electrotberapy stimulation therapy in the treatment of anxiety disorders. Method: One hundred and twenty patients with anxiety disorder were randomly divided into the study group and the CES control group, each group having 60 cases. All of them were given treatment of paroxetine (Paxil) for 6 weeks. In addition, patients in the study group con...
متن کاملComparing the Effectiveness of Paroxetine, Attention Modification Program and Combination of both on Improving Social Anxiety Symptoms
Introduction: Although the effectiveness of paroxetine and Attention Modification Program has been studied separately in treating social anxiety disorder, there has been no research comparing them according to the literature. The aim of this study was to compare the effectiveness of paroxetine, Attention Modification Program (AMP) and combination of both on improving the Social Anxiety Symptoms...
متن کامل